Serum protein changes during antituberculosis therapy.
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001798:Blood Proteins / Q000032:analysis*; D005260:Female; D006801:Humans; D007122:Immunoelectrophoresis; D007075:Immunoglobulin M / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000627:therapeutic use; D014376:Tuberculosis / Q000097:blood* / Q000145:classification / Q000188:drug therapy; D005719:gamma-Globulins / Q000032:analysis*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001798:Blood Proteins; D007075:Immunoglobulin M; D005719:gamma-Globulins; D011718:Pyrazinamide